On the other hand, PTEN levels were checked in a study using the N9831 trial, which included a lot of people with Her2+ BC who were randomly assigned to TRS treatment or no TRS therapy at all, along with combination chemotherapy regimens after surgery. This evidence concerns the gene ERBB2 and breast cancer.